Zirabev and Weight increased - a phase IV clinical study of FDA data

Summary:

Weight increased is reported as a side effect among people who take Zirabev (bevacizumab-bvzr), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Dexamethasone, and have Glioblastoma.

The phase IV clinical study analyzes which people have Weight increased when taking Zirabev. It is created by eHealthMe based on reports of 614 people who have side effects when taking Zirabev from the FDA, and is updated regularly.

What is Zirabev?

Zirabev has active ingredients of bevacizumab-bvzr. eHealthMe is studying from 614 Zirabev users. Check the latest studies of Zirabev.

What is Weight increased?

Weight increased is found to be associated with 2,885 drugs and 3,951 conditions by eHealthMe. Check the latest studies of Weight increased.

On Jul, 11, 2026

614 people reported to have side effects when taking Zirabev.
Among them, 38 people (6.19%) have Weight increased.

Among these 38 people:

How long have people been on Zirabev when they have Weight increased? *

What is the gender of people who have Weight increased when taking Zirabev? *

female: 55.26 %
male: 44.74 %

What is the age of people who have Weight increased when taking Zirabev? *

What are other drugs people take besides Zirabev? *

What are other side effects people have besides Weight increased? *

High Blood Pressure: 10 people, 26.32%
Neoplasm Progression (growth of tumour): 10 people, 26.32%
Weight Decreased: 10 people, 26.32%
Fatigue (feeling of tiredness): 8 people, 21.05%
Blood Pressure Fluctuation: 8 people, 21.05%
Blood Pressure Systolic Increased: 8 people, 21.05%
Death: 7 people, 18.42%
Heart Rate Decreased: 7 people, 18.42%
Pain In Extremity: 7 people, 18.42%
Malaise (a feeling of general discomfort or uneasiness): 7 people, 18.42%

What are the existing conditions these people have? *

Glioblastoma (most common and most aggressive malignant primary brain tumour in humans): 14 people, 36.84%
Hereditary Haemorrhagic Telangiectasia (hereditary -development of multiple abnormalities in the blood vessels): 5 people, 13.16%
Oligodendroglioma (a type of glioma that are believed to originate from the oligodendrocytes of the brain or from a glial precursor cell): 2 people, 5.26%
Malignant Glioma (cancerous tumour of brain a cancer tumour of uncertain origin that arises both in soft tissue and bone): 2 people, 5.26%
Glioma (a type of tumour that starts in the brain or spine): 2 people, 5.26%
Renal Cancer Metastatic (cancer of kidney spreads to other part): 1 person, 2.63%
Post Herpetic Neuralgia (neuralgia caused by the varicella zoster virus): 1 person, 2.63%
Metastases To Lung (cancer spreads to lung): 1 person, 2.63%
Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 1 person, 2.63%
Colon Cancer Metastatic (cancer of colon spreads to other part of body): 1 person, 2.63%

* Approximation only. Some reports may have incomplete information.

Do you take Zirabev and have Weight increased?

- Check whether Weight increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zirabev:

Zirabev (614 reports)

Weight increased treatments and more:

Weight increased (279,369 reports)

Browse all side effects of Zirabev:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weight increased:

Weight increased (2,885 drugs)

Browse all the conditions that are associated with Weight increased:

Weight increased (3,951 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on bevacizumab-bvzr (the active ingredients of Zirabev) and Zirabev (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.